Status | Study |
RECRUITING |
Study Name: A Study to Assess the Safety and Efficacy of IC265 Ophthalmic Solution for Dry Eye in Adult Participants Condition: Dry Eye Syndromes Date: 2023-08-08 Interventions: 1 drop will be instilled in each eye twice a day |
ACTIVE_NOT_RECRUITING |
Study Name: Efficacy and Safety Evaluation of Tavilermide Ophthalmic Solution for the Treatment of Dry Eye Condition: Dry Eye Syndromes Date: 2023-04-27 Interventions: Twice a day topicial dosing |
RECRUITING |
Study Name: OTX-DED for the Short-term Treatment of the Symptoms of Dry Eye Disease (DED) Condition: Dry Eye Syndromes Date: 2023-03-24 Interventions: 0.3mg dexamethasone ophthalmic insert |
RECRUITING |
Study Name: OTX-DED for the Short-term Treatment of the Symptoms of Dry Eye Disease (DED) Condition: Dry Eye Syndromes Date: 2023-03-24 Interventions: 0.3mg dexamethasone ophthalmic insert |
COMPLETED |
Study Name: Clinical Trial to Evaluate the Safety and Efficacy of SCAI-001 Compared to Restasis Condition: Dry Eye Syndromes Date: 2023-02-08 Interventions: BID for 12weeks |
RECRUITING |
Study Name: Effect of Topical Antioxidants in Dry Eye Disease and Diabetic Retinopathy Condition: Dry Eye Syndromes Date: 2022-05-30 Interventions: It consists of a preservative-free eye drop composed of 100 mg cross-linked hyaluronic acid, 100 mg coenzyme Q10, 500 mg vitamin E TPGS (D-alpha-tocop |
Recruiting |
Study Name: Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome : ARISE-2 Condition: Dry Eye Syndrome Date: 2016-11-23 Interventions: Drug: RGN-259 A preservative-f |
Enrolling by invitation |
Study Name: Comparing the Quality of Topical Autologous Serum in Different Etiologies of Dry Eye Syndrome Condition: Dry Eye Syndrome Date: 2016-01-10 |
Completed |
Study Name: Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome: ARISE-1 Condition: Dry Eye Syndrome Date: 2015-10-26 Interventions: Drug: RGN-259 A preservative-f |
Completed |
Study Name: A Retrospective Analysis of Restasis® Benefits in Dry Eye Contact Lens Patients Condition: Dry Eye Syndrome Date: 2015-07-29 Interventions: Other: No Intervention No drug is administered in this study |